Store

Home
Regeneron Pharmaceuticals Inc
Rensselaer Mar 2024 483

483 Document: Regeneron Pharmaceuticals Inc, Mar 22, 2024

Bijoy Panicker, FDA Investigator
Ogechi C. Nna, FDA Investigator

FDANews 483 Regeneron Pharmaceuticals Inc Mar 22 2024 top

Bijoy Panicker FDA Investigator Ogechi C. Nna FDA Investigator

On Mar 22, 2024, the FDA inspected Regeneron Pharmaceuticals Inc's Rensselaer site. Explore the inspectional observations.

Regeneron Pharmaceuticals Inc

483 Document

Issued: Mar 22, 2024

Details

Human DrugsInspection
Rensselaer / United States
10 days

Available for Download - $199

[email protected]
+1 (650) 646-4996

About

About Us
Terms of Service
Privacy Policy
Support

GMP Resources

FDA Inspections DB

FDA Form 483 Database

Document Review

Related Apps

Quality Regulatory Intelligence

Redica Platform

Formerly FDAzilla, Redica is a data analytics platform built for the life sciences to improve product quality and reduce regulatory risk.

Clinical Trials Analytics

Clincosm

Marketplace connecting patients to clinical trials to accelerate patient recruitment is accelerating medicine

Productivity

CalendarCrush

App for calendar-driven people to account and bill for their time

Spectator Sports

BlitzSports

Score Clock App for youth sports parents asked to be time-keeper. This is the scorekeeping of the future.

Copyright © 2007 - 2024 Zymergi, Inc.